Evidence map›Paper›PMID 37851513›Full record

ArticleEuropace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology2023

Optimal interlesion distance for 90 and 50 watt radiofrequency applications with low ablation index values: experimental findings in a chronic ovine model.

Agustín Alfonso Bortone, F Daniel Ramirez, Marion Constantin, Clara Bortone, Caroline Hébert, Justine Constantin, Patric Bialas, Luca Rosario Limite

Open access · hybridAbstract read
In one paragraph

Article in Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.2field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Personalized pulmonary vein isolation with very high-power short-duration lesions guided by left atrial wall thickness: the QDOT-by-LAWT randomized trial.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2024
    Trial
  2. Comparison of very high-power short-duration and ablation index guided catheter ablation for cavotricuspid isthmus block.Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 3 countries.

Agustín Alfonso BortoneELSAN, Service de Cardiologie, Hôpital Privé Les Franciscaines, 3 Rue Jean Bouin, 30000 Nîmes, France.ORCID 0000-0001-9568-2806
F Daniel RamirezDivision of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.ORCID 0000-0002-4350-1652
Marion ConstantinL'Institut de RYthmologie et modélisation Cardiaque (LIRYC), Université de Bordeaux, 33600 Pessac, France.
Clara BortoneFaculté de Médecine, Université de Montpellier, Montpellier, France.
Caroline HébertBiosense-Webster France, Johnson & Johnson, 92787 Issy-les-Moulineaux, France.
Justine ConstantinBiosense-Webster France, Johnson & Johnson, 92787 Issy-les-Moulineaux, France.
Patric BialasDepartment of Anesthesiology, Saarland Medical University, Homburg, Germany.
Luca Rosario LimiteELSAN, Service de Cardiologie, Hôpital Privé Les Franciscaines, 3 Rue Jean Bouin, 30000 Nîmes, France.ORCID 0000-0003-1600-3137
Hôpital Privé Jean Mermo · FRJohnson & Johnson (France) · FRSaarland University · DEUniversité de Bordeaux · FRUniversité de Montpellier · FRUniversity of Ottawa · CA

Funding

Biosense Webster, IncInvestigator-Initiated Pre-Clinical Study Program BWI-IIS-651Irvine
6 · The paper itself

Abstract

aimsThe optimal interlesion distance (ILD) for 90 and 50 W radiofrequency applications with low ablation index (AI) values in the atria has not been established. Excessive ILDs can predispose to interlesion gaps, whereas restrictive ILDs can predispose to procedural complications. The present study sought, therefore, to experimentally determine the optimal ILD for 90 W-4 s and 50 W applications with low AI values to optimize catheter ablation outcomes in humans. METHODS AND

resultsPosterior intercaval lines were created in eight adult sheep using CARTO and the QDOT-MICRO catheter in a temperature-controlled mode. In four animals, the lines were created with 50 W applications, a target AI value ≥350, and ILDs of 6, 5, 4, and 3 mm, respectively. In the other four animals, the lines were created with 90 W-4 s applications and ILDs of 6, 5, 4, and 3 mm, respectively. Activation maps were created immediately after ablation and at 21 days to assess linear block prior to gross and histological analyses. All eight lines appeared transmural and continuous on histology. However, for 50 W-only applications with an ILD of 3 mm resulted in durable linear electrical block, whereas for 90 W applications, only the lines with ILDs of 4 and 3 mm were blocked. No complications were detected during ablation procedures, but all power and ILD combinations except 50 W-6 mm resulted in asymptomatic shallow lung lesions.

conclusionIn the intercaval region in sheep, for 50 W applications with an AI value of ∼370, the optimal ILD is 3 mm, whereas for 90 W-4 s applications, the optimal ILD is 3-4 mm.

Indexed as

Atrial FibrillationCatheter AblationLung Diseases, InterstitialPulmonary VeinsAdultAnimalsCathetersHeart AtriaHumansSheepTreatment OutcomeAtrial fibrillationHigh-powerInterlesion distanceOvine modelPulmonary vein isolationRadiofrequencyThin-walled structures

Identifiers

PMID37851513
PMCPMC10629717
OpenAlexW4387731171

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.